Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bronchiolitis | 6 | 2019 | 297 | 1.31 | Why? |
| Virology | 2 | 2018 | 489 | 1.03 | Why? |
| Interferon Type I | 5 | 2021 | 2789 | 0.92 | Why? |
| Respiratory Syncytial Virus Infections | 7 | 2019 | 1234 | 0.76 | Why? |
| JC Virus | 1 | 2018 | 39 | 0.72 | Why? |
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 55 | 0.69 | Why? |
| Virus Diseases | 6 | 2018 | 3779 | 0.63 | Why? |
| Viruses | 4 | 2018 | 2238 | 0.62 | Why? |
| Interferons | 8 | 2021 | 2885 | 0.61 | Why? |
| HIV-1 | 8 | 2019 | 3365 | 0.59 | Why? |
| Interferon-gamma | 6 | 2019 | 2711 | 0.57 | Why? |
| Interleukins | 3 | 2019 | 762 | 0.55 | Why? |
| DNA, Viral | 7 | 2019 | 2521 | 0.53 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.51 | Why? |
| Cystic Fibrosis | 2 | 2020 | 1104 | 0.51 | Why? |
| DNA Viruses | 2 | 2019 | 184 | 0.46 | Why? |
| Bronchiolitis, Viral | 3 | 2018 | 71 | 0.42 | Why? |
| Health Communication | 1 | 2021 | 1120 | 0.41 | Why? |
| Torque teno virus | 3 | 2019 | 73 | 0.39 | Why? |
| Virus Activation | 3 | 2019 | 480 | 0.38 | Why? |
| HIV Infections | 11 | 2020 | 11620 | 0.37 | Why? |
| SARS Virus | 5 | 2020 | 13021 | 0.36 | Why? |
| Respiratory Syncytial Virus, Human | 4 | 2019 | 846 | 0.35 | Why? |
| Leukocytes, Mononuclear | 5 | 2019 | 2115 | 0.34 | Why? |
| Picornaviridae Infections | 5 | 2018 | 544 | 0.33 | Why? |
| Hepatitis C | 3 | 2016 | 1514 | 0.33 | Why? |
| Rhinovirus | 5 | 2018 | 979 | 0.32 | Why? |
| Intestinal Mucosa | 3 | 2019 | 1046 | 0.31 | Why? |
| Research | 1 | 2018 | 2115 | 0.30 | Why? |
| Gene Expression | 3 | 2021 | 3332 | 0.28 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.28 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.27 | Why? |
| Molecular Diagnostic Techniques | 2 | 2018 | 4239 | 0.27 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.26 | Why? |
| Genotype | 5 | 2019 | 4697 | 0.24 | Why? |
| Epidemics | 2 | 2020 | 6407 | 0.23 | Why? |
| DNA Virus Infections | 2 | 2019 | 88 | 0.23 | Why? |
| Antiviral Agents | 9 | 2021 | 41703 | 0.22 | Why? |
| Hepatitis B | 3 | 2017 | 888 | 0.21 | Why? |
| Merkel cell polyomavirus | 1 | 2019 | 5 | 0.21 | Why? |
| Virus Replication | 6 | 2020 | 14331 | 0.20 | Why? |
| Probiotics | 2 | 2018 | 694 | 0.20 | Why? |
| Social Media | 1 | 2021 | 5798 | 0.20 | Why? |
| RNA Viruses | 1 | 2007 | 824 | 0.19 | Why? |
| Antigens, Viral | 1 | 2016 | 6298 | 0.19 | Why? |
| Medical Laboratory Personnel | 1 | 2021 | 254 | 0.19 | Why? |
| Paramyxoviridae Infections | 2 | 2016 | 364 | 0.19 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 13720 | 0.19 | Why? |
| Flavanones | 1 | 2020 | 141 | 0.19 | Why? |
| Intraepithelial Lymphocytes | 1 | 2019 | 52 | 0.19 | Why? |
| Microbial Interactions | 1 | 2018 | 67 | 0.19 | Why? |
| Rome | 1 | 2020 | 497 | 0.18 | Why? |
| Metronidazole | 1 | 2018 | 59 | 0.18 | Why? |
| Receptors, Cytokine | 1 | 2018 | 75 | 0.18 | Why? |
| Infant | 11 | 2020 | 30274 | 0.18 | Why? |
| Genome, Viral | 2 | 2018 | 13157 | 0.18 | Why? |
| Polyomavirus Infections | 1 | 2019 | 156 | 0.17 | Why? |
| Virus Latency | 1 | 2019 | 251 | 0.17 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.17 | Why? |
| HIV Integrase | 1 | 2017 | 67 | 0.17 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.17 | Why? |
| Italy | 12 | 2020 | 38444 | 0.16 | Why? |
| Bronchoalveolar Lavage | 1 | 2020 | 603 | 0.16 | Why? |
| Interferon-beta | 2 | 2018 | 979 | 0.16 | Why? |
| Parvoviridae Infections | 2 | 2016 | 222 | 0.16 | Why? |
| Humans | 55 | 2021 | 930598 | 0.16 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2018 | 610 | 0.15 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.15 | Why? |
| Gene Expression Regulation, Viral | 2 | 2019 | 925 | 0.15 | Why? |
| Th1 Cells | 2 | 2019 | 1228 | 0.15 | Why? |
| Klebsiella Infections | 1 | 2020 | 466 | 0.15 | Why? |
| Viremia | 3 | 2019 | 1020 | 0.15 | Why? |
| Anti-HIV Agents | 2 | 2019 | 2209 | 0.15 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.14 | Why? |
| Oropharynx | 2 | 2021 | 1581 | 0.14 | Why? |
| Anti-Retroviral Agents | 3 | 2020 | 1099 | 0.14 | Why? |
| HIV Seropositivity | 1 | 2017 | 320 | 0.14 | Why? |
| Klebsiella pneumoniae | 1 | 2020 | 658 | 0.14 | Why? |
| Semen | 1 | 2020 | 550 | 0.14 | Why? |
| beta-Lactamases | 1 | 2020 | 759 | 0.13 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.13 | Why? |
| Interleukin-17 | 1 | 2019 | 602 | 0.13 | Why? |
| Interferon-alpha | 2 | 2018 | 1442 | 0.13 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.13 | Why? |
| Hematologic Neoplasms | 2 | 2017 | 2105 | 0.13 | Why? |
| Hematologic Diseases | 1 | 2020 | 614 | 0.13 | Why? |
| Hospitalization | 8 | 2019 | 54280 | 0.13 | Why? |
| Hematopoietic Stem Cell Transplantation | 2 | 2017 | 2426 | 0.13 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.13 | Why? |
| Epigenesis, Genetic | 1 | 2019 | 711 | 0.13 | Why? |
| Herpesviridae Infections | 1 | 2014 | 172 | 0.12 | Why? |
| Herpesvirus 6, Human | 1 | 2014 | 162 | 0.12 | Why? |
| Respiratory Tract Infections | 2 | 2019 | 6817 | 0.12 | Why? |
| Drug Synergism | 2 | 2006 | 833 | 0.12 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.12 | Why? |
| Respiratory Syncytial Viruses | 2 | 2016 | 612 | 0.12 | Why? |
| Th17 Cells | 1 | 2017 | 657 | 0.11 | Why? |
| Recurrence | 5 | 2020 | 3675 | 0.11 | Why? |
| Weather | 1 | 2017 | 581 | 0.11 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.11 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.11 | Why? |
| T-Lymphocyte Subsets | 1 | 2019 | 1387 | 0.11 | Why? |
| Herpesvirus 4, Human | 1 | 2014 | 387 | 0.11 | Why? |
| Lymphocyte Activation | 2 | 2020 | 2742 | 0.11 | Why? |
| Infant, Newborn | 7 | 2020 | 23105 | 0.11 | Why? |
| Coinfection | 4 | 2020 | 6820 | 0.11 | Why? |
| Clostridium Infections | 1 | 2018 | 595 | 0.11 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.11 | Why? |
| Hospitals, University | 2 | 2020 | 4173 | 0.10 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.10 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.10 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.10 | Why? |
| RNA, Viral | 3 | 2020 | 32276 | 0.10 | Why? |
| Metapneumovirus | 2 | 2016 | 465 | 0.10 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.10 | Why? |
| Viral Interference | 1 | 1989 | 33 | 0.10 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.10 | Why? |
| Cytomegalovirus | 1 | 2014 | 600 | 0.10 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.09 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.09 | Why? |
| Viral Load | 5 | 2020 | 15850 | 0.09 | Why? |
| Nasopharynx | 4 | 2020 | 10224 | 0.09 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.09 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.09 | Why? |
| Vesiculovirus | 1 | 2008 | 153 | 0.09 | Why? |
| Hepacivirus | 2 | 2016 | 1509 | 0.09 | Why? |
| Newcastle disease virus | 1 | 2008 | 108 | 0.09 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4545 | 0.09 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.09 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2020 | 5837 | 0.09 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.08 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.08 | Why? |
| RNA, Messenger | 4 | 2020 | 5131 | 0.08 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.08 | Why? |
| Feces | 1 | 2020 | 4235 | 0.08 | Why? |
| Gastrointestinal Tract | 1 | 2014 | 1113 | 0.08 | Why? |
| Reagent Kits, Diagnostic | 1 | 2016 | 2149 | 0.08 | Why? |
| Pharmaceutical Preparations | 1 | 2020 | 1897 | 0.08 | Why? |
| 2',5'-Oligoadenylate Synthetase | 1 | 2006 | 205 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.07 | Why? |
| Myxovirus Resistance Proteins | 1 | 2004 | 77 | 0.07 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.07 | Why? |
| Male | 22 | 2021 | 367725 | 0.07 | Why? |
| GTP-Binding Proteins | 1 | 2004 | 132 | 0.07 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Vero Cells | 3 | 2020 | 14117 | 0.06 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.06 | Why? |
| MicroRNAs | 1 | 2016 | 1787 | 0.06 | Why? |
| Species Specificity | 1 | 2007 | 1356 | 0.06 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.06 | Why? |
| Human bocavirus | 2 | 2016 | 142 | 0.06 | Why? |
| Transcriptome | 1 | 2016 | 3466 | 0.06 | Why? |
| Female | 19 | 2021 | 380317 | 0.06 | Why? |
| Secondary Prevention | 2 | 2017 | 762 | 0.06 | Why? |
| Child | 5 | 2021 | 70012 | 0.06 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.05 | Why? |
| Clinical Trials as Topic | 2 | 2020 | 7330 | 0.05 | Why? |
| Hydroxamic Acids | 1 | 2019 | 43 | 0.05 | Why? |
| Sequence Analysis, DNA | 2 | 2019 | 2830 | 0.05 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.05 | Why? |
| Air Pollutants | 1 | 2017 | 3110 | 0.05 | Why? |
| Ubiquitins | 1 | 2021 | 202 | 0.05 | Why? |
| Semen Analysis | 1 | 2020 | 235 | 0.05 | Why? |
| Histone Deacetylase Inhibitors | 1 | 2019 | 79 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2020 | 51949 | 0.05 | Why? |
| Proteins | 1 | 2006 | 921 | 0.05 | Why? |
| Adult | 11 | 2021 | 244371 | 0.05 | Why? |
| Air Pollution | 1 | 2017 | 3504 | 0.05 | Why? |
| Biomarkers | 2 | 2019 | 23361 | 0.05 | Why? |
| Receptors, Interferon | 1 | 2018 | 64 | 0.05 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Cells, Cultured | 2 | 2008 | 5835 | 0.04 | Why? |
| Acute Disease | 2 | 2009 | 6029 | 0.04 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.04 | Why? |
| Seasons | 3 | 2017 | 4071 | 0.04 | Why? |
| Immunocompetence | 1 | 2019 | 280 | 0.04 | Why? |
| HIV Reverse Transcriptase | 1 | 2017 | 104 | 0.04 | Why? |
| Gene Expression Profiling | 1 | 2008 | 3788 | 0.04 | Why? |
| Mucous Membrane | 1 | 2019 | 305 | 0.04 | Why? |
| Prevalence | 4 | 2020 | 25773 | 0.04 | Why? |
| Bacterial Toxins | 1 | 2018 | 185 | 0.04 | Why? |
| Repressor Proteins | 1 | 2018 | 232 | 0.04 | Why? |
| Lipopolysaccharide Receptors | 1 | 2019 | 357 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Biomedical Research | 1 | 2016 | 5270 | 0.04 | Why? |
| HIV Integrase Inhibitors | 1 | 2017 | 173 | 0.04 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2017 | 309 | 0.04 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.04 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.04 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.04 | Why? |
| Eosinophilia | 1 | 2018 | 292 | 0.03 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2004 | 3786 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2020 | 865 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Papillomaviridae | 1 | 2017 | 404 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 952 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Lymphokines | 1 | 1992 | 13 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2019 | 844 | 0.03 | Why? |
| Cell Division | 1 | 1992 | 136 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Animals | 4 | 2020 | 78931 | 0.03 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Sulfonamides | 1 | 2019 | 1294 | 0.03 | Why? |
| Prospective Studies | 4 | 2019 | 43301 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.02 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2019 | 4758 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Pneumonia | 1 | 2007 | 5652 | 0.02 | Why? |
| Research Design | 1 | 2003 | 5830 | 0.02 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.02 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Length of Stay | 2 | 2017 | 11042 | 0.02 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Cities | 1 | 2017 | 4937 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| Nasal Cavity | 1 | 2009 | 909 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.01 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.01 | Why? |
| Killer Cells, Natural | 1 | 1992 | 2093 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Organ Transplantation | 1 | 2016 | 2616 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Macrophages | 1 | 1992 | 2784 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Adjuvants, Immunologic | 1 | 1989 | 1709 | 0.01 | Why? |
| Asthma | 1 | 2017 | 4383 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.01 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Galactose Oxidase | 1 | 1992 | 1 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Influenza, Human | 1 | 2016 | 10779 | 0.01 | Why? |
| Leucine | 1 | 1992 | 121 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Cytotoxicity, Immunologic | 1 | 1992 | 287 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Interleukin-2 | 1 | 1992 | 443 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
| Interleukin-1 | 1 | 1992 | 438 | 0.01 | Why? |
| Chronic Disease | 1 | 2001 | 5139 | 0.01 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 1992 | 2483 | 0.00 | Why? |
| Disease Outbreaks | 1 | 2009 | 27595 | 0.00 | Why? |